Harold Selick
Chairman en MOLECULAR TEMPLATES, INC. .
Fortuna: 816 017 $ al 31/03/2024
Perfil
Harold E.
Selick is the founder of Epiphany Biosciences, Inc. (founded in 2001) and Camitro UK Ltd.
(founded in 1999), where he held the title of Chairman.
Dr. Selick is also the founder of ArQule UK Ltd.
Dr. Selick's current job(s) include Chief Executive Officer at Hinge Bio, Inc. (since 2023), Chairman at Protagonist Therapeutics, Inc. (since 2009), Chairman at Molecular Templates, Inc. (since 2017), Independent Director at Protagonist Pty Ltd., Director at Amunix, Inc., Director at Molecular Templates OpCo, Inc., and Venture Partner at Mission Bay Capital Management, Inc. Dr. Selick's former job(s) include Chairman & Chief Executive Officer at Threshold Pharmaceuticals, Inc. (2002-2017), President & Chief Executive Officer at Camitro Corp.
(1999-2002), Chairman at DiObex, Inc., Chairman at Catalyst Bioscience, Inc. (2003-2015), Chairman at Catalyst Biosciences, Inc. (2015-2018), Director at Amunix Pharmaceuticals, Inc., Staff Scientist at Protein Design Labs, Inc. (1983-1985), Principal at Anergen, Inc., Vice President-Research at Glaxo Wellcome Plc, Partner at Sofinnova Investments, Inc. (2002-2007), Vice President-Research at Affymax Research Institute (1992-2002), and Vice Chancellor-Business Development & Innovation at The University of California, San Francisco (2017-2022).
Dr. Selick's education includes undergraduate and doctorate degrees from the University of Pennsylvania.
Dr. Selick is also the founder of ArQule UK Ltd...
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 07/03/2024 | 27 996 ( 0.05% ) | 809 924 $ | 31/03/2024 | |
| 27/10/2023 | 2 720 ( 0.05% ) | 6 093 $ | 31/03/2024 |
Cargos activos de Harold Selick
| Empresas | Cargo | Inicio |
|---|---|---|
| PROTAGONIST THERAPEUTICS, INC. | Chairman | 19/03/2014 |
| MOLECULAR TEMPLATES, INC. | Chairman | 01/08/2017 |
Amunix, Inc.
 Amunix, Inc. Pharmaceuticals: MajorHealth Technology Amunix, Inc. develops protein pharmaceuticals. It offers XTEN which is hydrophilic, unstructured, biodegradable polypeptides that impart a number of favorable properties upon the molecules to which they are attached. The company was founded by Volker Schellenberger and Willem Stemmer in 2006 and is headquartered in Mountain View, CA. | Director/Board Member | - |
Mission Bay Capital Management, Inc.
 Mission Bay Capital Management, Inc. Investment ManagersFinance Mission Bay Capital Management Inc (Mission Bay Capital) is a venture capital firm founded in 2009. The firm is headquartered in San Francisco, California. | Private Equity Investor | - |
Molecular Templates OpCo, Inc.
 Molecular Templates OpCo, Inc. Financial ConglomeratesFinance Molecular Templates OpCo, Inc. provides medical services. The company is headquartered in Austin, TX. | Director/Board Member | - |
Protagonist Pty Ltd.
 Protagonist Pty Ltd. Pharmaceuticals: MajorHealth Technology Protagonist Pty Ltd. operates as a clinical-stage biopharmaceutical company. Its proprietary technology platform focused on discovering and developing peptide-based new chemical entities to address significant unmet medical needs. The company was founded on September 19, 2001 and is headquartered in Brisbane, Australia. | Chairman | - |
Hinge Bio, Inc.
 Hinge Bio, Inc. BiotechnologyHealth Technology Hinge Bio, Inc. is a holding company, which engages in the development of specific and multi-specific antibodies. The company is headquartered in Burlingame, CA. | Chief Executive Officer | 18/01/2023 |
Antiguos cargos conocidos de Harold Selick.
| Empresas | Cargo | Fin |
|---|---|---|
| The University of California, San Francisco | Corporate Officer/Principal | 01/12/2022 |
| PDL BIOPHARMA, INC. | Chairman | 31/12/2019 |
| ░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░ ░░░░ ░░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
Formación de Harold Selick.
| University of Pennsylvania | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| PROTAGONIST THERAPEUTICS, INC. | Health Technology |
| MOLECULAR TEMPLATES, INC. | Health Technology |
| Empresas privadas | 20 |
|---|---|
Protein Design Labs, Inc.
 Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Protein Design Labs, Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a company of development of humanized antibodies, It has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products. | Health Technology |
| Anergen, Inc. | Health Technology |
| Glaxo Wellcome Plc | Health Technology |
Threshold Pharmaceuticals, Inc.
 Threshold Pharmaceuticals, Inc. BiotechnologyHealth Technology Threshold Pharmaceuticals, Inc. engages in the development of therapeutics for treating tumors. It offers the Evofosfamide which designed as a prodrug that is activated under the extreme hypoxic conditions commonly found in tumors, but not typically in healthy tissues, and TH-3424 which is a small-molecule drug candidate for the treatment of liver, castrate resistant prostate cancer, T-cell acute lymphoblastic leukemias, and other cancers. The company was founded by Jeffrey W. Bird on October 17, 2001 and is headquartered in South San Francisco, CA | Health Technology |
DiObex, Inc.
 DiObex, Inc. Pharmaceuticals: MajorHealth Technology DiObex, Inc. develops therapies for metabolic disease treatment. Its products address the markets for the treatment of diabetes and its co-morbidities such as hypertension, dyslipidemia, and visceral adiposity. The company was founded in 2003 and is headquartered in San Francisco, CA. | Health Technology |
Catalyst Bioscience, Inc. /Old/
 Catalyst Bioscience, Inc. /Old/ Medical SpecialtiesHealth Technology Catalyst Bioscience, Inc. develops and markets catalytic biopharmaceutical products. Its technology consists of methods to identify proteases with tailor-made specificity or improved pharmacological properties. The company was founded by Charles Craik, Sandra Waugh Ruggles and Christopher Thanos in 2003 and is headquartered in South San Francisco, CA. | Health Technology |
Protagonist Pty Ltd.
Protagonist Pty Ltd. Pharmaceuticals: MajorHealth Technology Protagonist Pty Ltd. operates as a clinical-stage biopharmaceutical company. Its proprietary technology platform focused on discovering and developing peptide-based new chemical entities to address significant unmet medical needs. The company was founded on September 19, 2001 and is headquartered in Brisbane, Australia. | Health Technology |
Epiphany Biosciences, Inc.
 Epiphany Biosciences, Inc. Medical SpecialtiesHealth Technology Epiphany Biosciences, Inc. develops therapeutic products and diagnostic technologies that treat and prevent the spread of pathogenic viruses. The firm develops therapeutics to prevent spread of varicella zoster virus (VZV), Epstein-Barr virus (EBV), and hepatitis C virus (HCV). The company was founded by David C Myles, Robert Charles Gallo, Harold E Selick and Frederick Volinsky in 2001 and is headquartered in San Francisco, CA. | Health Technology |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Finance |
Affymax Research Institute
 Affymax Research Institute Miscellaneous Commercial ServicesCommercial Services Part of GSK Plc, Affymax Research Institute is a private company that researches and develops pharmaceutical products. The company is based in Palo Alto, CA. Affymax Research Institute was acquired by Affymax, Inc. from GSK Plc on July 30, 2001. | Commercial Services |
Camitro Corp.
 Camitro Corp. Miscellaneous Commercial ServicesCommercial Services Camitro Corporation is a drug discovery technology development company based in Menlo Park, California. Camitro is dedicated to the development and application of innovative computational technologies for the design, selection and optimization of novel drug candidates. The Company's predictive models enable scientists to assess ADMET properties of chemical compounds throughout the discovery process, from the earliest stages of compound selection and library design through lead candidate evaluation and re-design. Its integrated platform of models permits the optimization of multiple ADMET properties simultaneously, at high throughput, based upon chemical structure alone | Commercial Services |
ArQule UK Ltd.
 ArQule UK Ltd. Pharmaceuticals: MajorHealth Technology Part of Galapagos NV, ArQule UK Ltd. is a private company that discovers and produces novel chemical compounds with commercial potential. ArQule UK Ltd. is based in Cambridge, UK. ArQule was acquired by Galapagos Biotech Ltd., a subsidiary of Galapagos NV from ArQule, Inc. on June 23, 2003. The British company was founded by Harold E. Selick. | Health Technology |
PDL BioPharma, Inc.
 PDL BioPharma, Inc. BiotechnologyHealth Technology PDL BioPharma, Inc. engages in the business of developing innovative therapeutics and healthcare technologies. It operates under the Medical Devices and Income Generating Assets segments. The Medical Devices segment focuses on the sale and lease of the LENSAR laser system which includes equipment, patient interface devices, procedure licenses, training, installation, warranty, and maintenance agreements. The Income Generating Assets segment offers notes and other long-term receivables; royalty rights, hybrid notes, and royalty receivables; equity investments; and royalties from issued patents covering the humanization of antibodies. The company was founded by Cary L. Queen and Laurence Jay Korn in 1986 and is headquartered in Reno, NV. | Health Technology |
Amunix, Inc.
Amunix, Inc. Pharmaceuticals: MajorHealth Technology Amunix, Inc. develops protein pharmaceuticals. It offers XTEN which is hydrophilic, unstructured, biodegradable polypeptides that impart a number of favorable properties upon the molecules to which they are attached. The company was founded by Volker Schellenberger and Willem Stemmer in 2006 and is headquartered in Mountain View, CA. | Health Technology |
Mission Bay Capital Management, Inc.
Mission Bay Capital Management, Inc. Investment ManagersFinance Mission Bay Capital Management Inc (Mission Bay Capital) is a venture capital firm founded in 2009. The firm is headquartered in San Francisco, California. | Finance |
Catalyst Biosciences, Inc.
 Catalyst Biosciences, Inc. BiotechnologyHealth Technology Catalyst Biosciences, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the development of novel medicines to address serious medical conditions. The company was founded on March 7, 1997 and is headquartered in South San Francisco, CA. | Health Technology |
Camitro UK Ltd.
 Camitro UK Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Merck & Co., Inc., Camitro UK Ltd. is a private company that operates commercial research institutions. The company is based in Cambridge, UK. The British company was founded by Harold E. Selick. | Commercial Services |
Amunix Pharmaceuticals, Inc.
 Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | Health Technology |
Hinge Bio, Inc.
Hinge Bio, Inc. BiotechnologyHealth Technology Hinge Bio, Inc. is a holding company, which engages in the development of specific and multi-specific antibodies. The company is headquartered in Burlingame, CA. | Health Technology |
Molecular Templates OpCo, Inc.
Molecular Templates OpCo, Inc. Financial ConglomeratesFinance Molecular Templates OpCo, Inc. provides medical services. The company is headquartered in Austin, TX. | Finance |
- Bolsa de valores
- Insiders
- Harold Selick
